Topical Application of the PI3Kβ-Selective Small Molecule Inhibitor TGX-221 Is an Effective Treatment Option for Experimental Epidermolysis Bullosa Acquisita.
Zillikens H, Kasprick A, Osterloh C, Gross N, Radziewitz M, Hass C, Hartmann V, Behnen-Härer M, Ernst N, Boch K, Vidarsson G, Visser R, Laskay T, Yu X, Petersen F, Ludwig RJ, Bieber K.
Zillikens H, et al. Among authors: ernst n.
Front Med (Lausanne). 2021 Sep 7;8:713312. doi: 10.3389/fmed.2021.713312. eCollection 2021.
Front Med (Lausanne). 2021.
PMID: 34557502
Free PMC article.